反応 #11697
ord-3f80ff37dc2a4555bcb5ef06034a0b77
反応方程式
反応物
試薬
反応条件
後処理
- 1その他after 16 h the resulting yellow solution was evaporated under vacuum
- 2workup.DISSOLUTIONThe residue was dissolved in ethyl acetate (150 mL)
- 3洗浄this was washed sequentially with 1.0 M aqueous hydrochloric acid (50 mL twice), 1.0 M aqueous sodium hydroxide (50 mL), water (50 mL), and brine (25 mL)
- 4乾燥dried over anhydrous sodium sulfate
- 5その他evaporated under vacuum
- 6その他to provide crude product
- 7その他The product was crystallized
- 8workup.DISSOLUTIONby dissolving in warm methanol (40 mL)
- 9workup.ADDITIONadding diethyl ether (100 mL)
- 10ろ過The crystals were filtered
- 11洗浄washed with diethyl ether (30 mL twice), and
- 12その他dried under vacuum
実験手順
A mixture of (S)-4-amino-2,3,4,5-tetrahydro-2-benzazepin-3(1H)-one hydrochloride (all of that prepared above), tetrahydrofuran (25 mL), 5-chloroindole-2-carboxylic acid (198 mg), 1-hydroxy-7-azabenzotriazole (150 mg), and 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (210 mg) was stirred at room temperature. Diisopropylethylamine (202 mg) was added, and after 16 h the resulting yellow solution was evaporated under vacuum. The residue was dissolved in ethyl acetate (150 mL), and this was washed sequentially with 1.0 M aqueous hydrochloric acid (50 mL twice), 1.0 M aqueous sodium hydroxide (50 mL), water (50 mL), and brine (25 mL), dried over anhydrous sodium sulfate, and evaporated under vacuum to provide crude product. The product was crystallized by dissolving in warm methanol (40 mL) and adding diethyl ether (100 mL). The crystals were filtered, washed with diethyl ether (30 mL twice), and dried under vacuum to provide the title compound (181 mg). HPLC/MS [M+H]+, 354.